Intrinsic Value

The intrinsic value of MD Medical Group Investments MKPAO (MDMG) under the Base Case is 1 859.97 RUB per share. Compared with the current market price of 1 295.6 RUB, the stock appears Undervalued by 30% .

The intrinsic value is calculated using the DCF method. The model assumes net margin falls to 22% by 2031, below its five-year average of 25%. Revenue grows about 17% a year over the next five years, close to its five-year pace of 18%. The value of the years after 2031 is tied to revenue, so margins count only until then.

Do our valuations actually work? See backtest results .

MDMG Intrinsic Value
₽1 859.97
Undervaluation 30%
Intrinsic Value
Price ₽1 295.6
Alert me when MDMG is below its intrinsic value
Today ₽1 115.98 · 13.9% below the current price

MDMG is valued in line with its history. A discount of this size has been typical over the past 5 years.

Alternatives to MDMG

Fundamental Analysis

What MD Medical Group Investments MKPAO Does

Health Care

MD Medical Group Investments MKPAO (International Public Joint-Stock Company MD Medical Group Investments), is a Russian-based investment holding company specializing in women’s and children’s healthcare and providing multifunctional healthcare. The company is headquartered in Kaliningrad, Kaliningradskaya Oblast and currently employs 13,388 full-time employees. The company went IPO on 2024-06-17.

Headquarters
Russia RU
Employees
13 388
IPO date
Jun 17, 2024
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue MDMG Research

Decided on MD Medical Group Investments MKPAO? Get an email when MDMG reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one MDMG stock?

The intrinsic value for MD Medical Group Investments MKPAO (MDMG) under the Base Case is 1 859.97 RUB.

Is MDMG stock undervalued or overvalued?

Compared with the current market price of 1 295.6 RUB, the stock appears Undervalued by 30% .

How reliable are our estimates? See how past valuations played out
Back to Top